Home・Listă Acțiuni・Bio-Techne Corp

Bio-Techne Corp

Deschisă

SectorSănătate

72.42 -0.04

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

72.38

Maxim

72.56

Indicatori cheie
By Trading Economics
Venit	3.6M 55M
Vânzări	9.8M 321M
P/E Medie Sector	62.336 56.659
EPS	0.49
Randament dividend	0.44
Marjă de profit	17.006
Angajați	3,000
EBITDA	-6.7M 92M

Recomandări
By TipRanks
Recomandări	Neutru
Prognoză pe 12 luni	-0.47% downside

Dividende
By Acuity
Randament dividend Medie Sector	0.44% 2.18%
Următoarele câștiguri	4 nov. 2026
Data viitoare de dividende	27 nov. 2026
Următoarea dată ex-dividende	16 nov. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	102M 11B
Deschiderea anterioară	72.46
Închiderea anterioară	72.42

Sentimentul știrilor

By Acuity

43%

57%

135 / 339 Clasament în Healthcare

Bio-Techne Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

28 aug. 2026, 19:46 UTC

Correlated Moves

Bio-Techne Corp is trading lower today, reflecting a broader decline in the biotech sector, including Charles River Laboratories International Inc.

27 aug. 2026, 23:31 UTC

Bio-Techne Corp shares are higher in after-market hours, though no specific news was identified. Recent economic data showed a decline in initial jobless claims.

19 aug. 2026, 19:27 UTC

Correlated Moves

Shares modestly higher, influenced by rise in iShares Biotechnology ETF.

18 aug. 2026, 21:41 UTC

Bio-Techne Corp shares are higher in after-market trading, peaking early in the session and remaining near the upper end of their one-month trading range.

17 aug. 2026, 19:16 UTC

Correlated Moves

Bio-Techne Corp is trading roughly flat amid broader market sentiment, with the Russell 2000 Index declining. Recent economic data has contributed to cautious conditions.

13 aug. 2026, 19:16 UTC

Correlated Moves

News

Bio-Techne Corp corrected its dividend record date to August 24, 2026. Shares are trading roughly flat amid broader market dynamics.

5 aug. 2026, 19:16 UTC

Correlated Moves

Bio-Techne Corp's shares are lower today, reflecting declines in the Russell 2000 Index. The stock remains near the upper end of its one-month trading range.

4 aug. 2026, 22:02 UTC

Correlated Moves

Bio-Techne Corp shares are higher in after-market trading, buoyed by positive sentiment from U.S.-Iran negotiations and gains in major technology stocks.

3 aug. 2026, 19:26 UTC

Correlated Moves

Bio-Techne Corp is advancing, reflecting broader market positivity amid gains in major tech stocks and falling energy prices. The stock is near its one-month trading range high.

31 iul. 2026, 22:02 UTC

Correlated Moves

Bio-Techne Corp shares are lower in after-market trading amid a broader market downturn, reflecting negative sentiment impacting price action.

30 iul. 2026, 18:26 UTC

Correlated Moves

Bio-Techne Corp is trading roughly flat as the broader market recovers from declines, influenced by rising Treasury yields and inflation concerns.

29 iul. 2026, 22:03 UTC

Bio-Techne Corp shares are lower in after-market hours, reflecting a decline since Wednesday's close amid cautious market sentiment and geopolitical tensions.

20 iul. 2026, 18:01 UTC

Bio-Techne Corp shares are lower today, with no specific news identified. Broader market pressures include rising yields and inflation concerns linked to oil prices.

Comparație

Modificare preț

Bio-Techne Corp Așteptări

Obiectiv de preț

By TipRanks

-0.47% jos

Prognoză pe 12 luni

Medie 72.11 USD -0.47%

Maxim 73 USD

Minim 65 USD

În baza a 11 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruBio-Techne Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

11 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 11 analiști care au acordat evaluări ale acțiunilor Bio-Techne Corp - Dist în ultimele 3 luni.

Sentiment

By Acuity

135 / 339 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Bio-Techne Corp

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company has strategic partnership with ALZpath, Inc. to accelerate breakthroughs in neurodegenerative disease research and treatment, including Alzheimer's disease. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.